Table 8. Estimated hypertension treatment costs, 2015 and 2030.
| 2015 | 2030 | |||
|---|---|---|---|---|
| Status quo | Scenario II* | |||
| Average medication (TL) | 183.3§ | 665.5¶ | 665.5 | |
| Ambulatory care/adult (TL) | 152.1 | 582.9 | 582.9 | |
| Cost in Billion TL | Additional cost in Billion TL (Scenario II—Status Quo) | |||
| Annual medication | 2.7 | 11.6 | 13.0 | 1.4 |
| Annual ambulatory care | 2.2 | 10.2 | 11.4 | 1.3 |
| Total treatment | 4.9 | 21.7 | 24.5 | 2.7 |
Note:
§Data provides the percentage of hypertensive people using a number of medications (1–4). In our analysis, we assume that each medication costs on average 17 TL per month in 2016.
¶ We projected the conversion rate between USD and TL based on data on the IMF WEO database, where the conversion rate is projected to increase by 5.5% per annum over the period 2018–2022. In our projection for 2030, we kept the rate constant at 5.5%.
* a 17% reduction in hypertension prevalence in 2030.